Amphastar Pharmaceuticals, Inc. Free Cash Flow 2012–2025
Amphastar Pharmaceuticals, Inc. reported $121.23M of free cash flow for fiscal 2025. That was 29.7% lower than fiscal 2024. Compared with fiscal 2020, the change was +417.8%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $121.23M | -29.7% |
| FY 2024 | $172.34M | +18.6% |
| FY 2023 | $145.34M | +123.1% |
| FY 2022 | $65.15M | -7.6% |
| FY 2021 | $70.54M | +201.3% |
| FY 2020 | $23.41M | +11209.7% |
| FY 2019 | $207,000 | +102.4% |
| FY 2018 | $-8.62M | -309.7% |
| FY 2017 | $4.11M | -76.1% |
| FY 2016 | $17.18M | +423.2% |
| FY 2015 | $-5.32M | -1061.1% |
| FY 2014 | $553,000 | -95.9% |
| FY 2013 | $13.40M | +154.1% |
| FY 2012 | $-24.78M | — |
Source: Amphastar Pharmaceuticals, Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open AMPH 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Amphastar Pharmaceuticals, Inc. reported $121.23M of free cash flow for fiscal 2025. That was 29.7% lower than fiscal 2024. Compared with fiscal 2020, the change was +417.8%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Amphastar Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAmphastar Pharmaceuticals, Inc. — frequently asked questions
What is Amphastar Pharmaceuticals, Inc.'s free cash flow?
Amphastar Pharmaceuticals, Inc. (AMPH) reported free cash flow of $121.23M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Amphastar Pharmaceuticals, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.